Mirae Asset Global Investments Co., Ltd. Harrow Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,056 shares of HROW stock, worth $47,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,056Holding current value
$47,868% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding HROW
# of Institutions
121Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$181 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$123 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$97.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$83.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$32.6 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.23B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...